Drug class
Glycosaminoglycan mixture; antithrombotic and venotonic agent
Mechanism of action
A natural glycosaminoglycan preparation containing heparan sulfate, dermatan sulfate, slow-moving heparin and chondroitin sulfate. It has reported anticoagulant, antithrombotic, endothelial-protective and wound-healing activity; mechanisms include modulation of coagulation and vascular smooth-muscle signalling.
General use cases
- Used in some countries for chronic venous disease and selected vascular disorders; topical mesoglycan/hyaluronic-acid medical devices are also used in wound management. Clinical use and authorisation are product- and jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
